Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

495 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
From research to the real world: buprenorphine in the decade of the Clinical Trials Network.
Ling W, Jacobs P, Hillhouse M, Hasson A, Thomas C, Freese T, Sparenborg S, McCarty D, Weiss R, Saxon A, Cohen A, Straus M, Brigham G, Liu D, McLaughlin P, Tai B. Ling W, et al. Among authors: saxon a. J Subst Abuse Treat. 2010 Jun;38 Suppl 1(Suppl 1):S53-60. doi: 10.1016/j.jsat.2010.01.009. J Subst Abuse Treat. 2010. PMID: 20307796 Free PMC article.
Factors affecting willingness to provide buprenorphine treatment.
Netherland J, Botsko M, Egan JE, Saxon AJ, Cunningham CO, Finkelstein R, Gourevitch MN, Renner JA, Sohler N, Sullivan LE, Weiss L, Fiellin DA; BHIVES Collaborative. Netherland J, et al. Among authors: saxon aj. J Subst Abuse Treat. 2009 Apr;36(3):244-51. doi: 10.1016/j.jsat.2008.06.006. Epub 2008 Aug 20. J Subst Abuse Treat. 2009. PMID: 18715741 Free PMC article.
Buprenorphine tapering schedule and illicit opioid use.
Ling W, Hillhouse M, Domier C, Doraimani G, Hunter J, Thomas C, Jenkins J, Hasson A, Annon J, Saxon A, Selzer J, Boverman J, Bilangi R. Ling W, et al. Among authors: saxon a. Addiction. 2009 Feb;104(2):256-65. doi: 10.1111/j.1360-0443.2008.02455.x. Addiction. 2009. PMID: 19149822 Free PMC article. Clinical Trial.
Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: a randomized trial.
Saxon AJ, Ling W, Hillhouse M, Thomas C, Hasson A, Ang A, Doraimani G, Tasissa G, Lokhnygina Y, Leimberger J, Bruce RD, McCarthy J, Wiest K, McLaughlin P, Bilangi R, Cohen A, Woody G, Jacobs P. Saxon AJ, et al. Drug Alcohol Depend. 2013 Feb 1;128(1-2):71-6. doi: 10.1016/j.drugalcdep.2012.08.002. Epub 2012 Aug 22. Drug Alcohol Depend. 2013. PMID: 22921476 Free PMC article. Clinical Trial.
Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology.
Mooney LJ, Nielsen S, Saxon A, Hillhouse M, Thomas C, Hasson A, Stablein D, McCormack J, Lindblad R, Ling W. Mooney LJ, et al. Among authors: saxon a. Contemp Clin Trials. 2013 Mar;34(2):196-204. doi: 10.1016/j.cct.2012.11.002. Epub 2012 Nov 16. Contemp Clin Trials. 2013. PMID: 23159524 Free PMC article. Clinical Trial.
Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START).
Potter JS, Marino EN, Hillhouse MP, Nielsen S, Wiest K, Canamar CP, Martin JA, Ang A, Baker R, Saxon AJ, Ling W. Potter JS, et al. Among authors: saxon aj. J Stud Alcohol Drugs. 2013 Jul;74(4):605-13. doi: 10.15288/jsad.2013.74.605. J Stud Alcohol Drugs. 2013. PMID: 23739025 Free PMC article. Clinical Trial.
495 results